Book a free demo
H-1B Data › Employers › Stealth BioTherapeutics Inc.
Check another employer
H-1B Sponsor Profile

Stealth BioTherapeutics Inc. — H-1B Visa Sponsorship Data

7 certified Labor Condition Applications on file with the U.S. Department of Labor, FY2021–FY2024.

Needham, MAActive FY2021–FY2024Full-Time RolesNot H-1B Dependent
● Data current through FY2024 · sourced from U.S. DOL OFLC, updated quarterly
Sponsors H-1B?
Yes
7 certified LCAs
FY2024 filings
2
most recent disclosure year
Median H-1B salary
$103,031
typical $85,819–$167,089
H-1B dependent?
No
per the employer's LCA attestation
Transfer share
12%
change-of-employer filings

2 items a DOL auditor would ask Stealth BioTherapeutics Inc. about

Since September 2025, DOL's Project Firewall opens H-1B investigations without waiting for a complaint. These checkpoints come from Stealth BioTherapeutics Inc.'s own public LCA filings (FY2022–FY2024) — the same records an investigator pulls first.

0 need attention2 to watch4 clear
Watch
25% of positions are amendments or material changes

Frequent amendments usually mean worksite or role changes; each one must be covered by a new LCA before the change takes effect.

Auditor asksFor each amendment: what changed, on what date, and was the new LCA certified before that date?
In your PAFAmended LCAs with dates aligned to the actual change; updated PAF entries.
Watch
20% of LCAs denied or withdrawn (FY2022–FY2024)

Withdrawn or denied LCAs are normal in isolation; a high share suggests workers were moved between filings and the paper trail needs checking.

Auditor asksWere the workers on withdrawn LCAs re-covered by a valid certified LCA before continuing work?
In your PAFWithdrawal acknowledgements; superseding LCAs; PAF entries showing the transition.
Clear
0% of certified LCAs are at Wage Level I

Level I is the entry-level prevailing-wage tier and the band DOL's Project Firewall reviews first for misclassification (senior duties filed at an entry-level wage). The national share is 17%.

Auditor asksHow was Level I justified for each role — required education, experience and the actual duties performed?
In your PAFPrevailing-wage determination and wage-level worksheet for every Level I LCA.
Clear
0% of LCAs offer a wage within 2% of the prevailing wage

Median offered wage is 39% above the DOL prevailing wage across 4 recent certified LCAs. Paying at the floor is lawful, but it invites the question of whether the wage level itself is right.

Auditor asksShow the actual wage paid (payroll) matches or exceeds the LCA wage for every worker, including benched time.
In your PAFActual-wage memorandum and pay records per LCA; wage-level rationale where the offered wage equals the PW.
Clear
2 worksites across 2 states

Each worksite needs its own 10-business-day LCA notice and a PAF record of that posting; a move to a new area of intended employment needs a new LCA before the worker starts there.

Auditor asksWhere is the posting record for each worksite, and were short-term placements tracked against the 30/60-day limits?
In your PAFPosting notices (or electronic-notice records) per worksite; new-worksite LCAs; placement log.
Clear
Not H-1B dependent (per LCA attestation)

No additional recruitment or non-displacement attestations apply.

Auditor asksDoes the current H-1B headcount still fall under the dependency threshold?
In your PAFHeadcount snapshot supporting the non-dependent attestation at each filing.
Are you Stealth BioTherapeutics Inc.? Get the private PAF / LCA gap check.
We compare these public filings against what must be in your Public Access Files and send you the gap list — free, within one business day. No platform migration, no commitment.
Get my private gap check →

Public DOL disclosure data can lag actual filings by a quarter. Descriptive only — not legal advice.

For job seekers

Considering a job at Stealth BioTherapeutics Inc.?

Does Stealth BioTherapeutics Inc. sponsor H-1B visas?

Yes — Stealth BioTherapeutics Inc. sponsors H-1B workers, with 7 certified LCAs on file (FY2021–FY2024), including 2 in FY2024. The median certified salary is $103,031 (P25 $85,819, P75 $167,089). 100% of its certified filings meet or exceed the prevailing wage.

What to Know Before Applying to Stealth BioTherapeutics Inc.

Salary range
Median $103,031, typical band $85,819–$167,089.
Transfers
12% transfer share — most sponsorship is for new or continuing roles.
Typical locations
Needham, MA, Norwich, NY.
Position type
100% of filings are full-time roles.
Common roles
Senior Regulatory Operations Specialis, Associate Director, Quality Control, Senior Manager, Quality Control.
Benchmark this employer in the H-1B database →
Looking for your next role?
See open positions on ElevateRecruit, the ElevateStaffing job board.
Browse open jobs →

Frequently asked questions

Yes. Stealth BioTherapeutics Inc. has 7 certified Labor Condition Applications (LCAs) on file with the U.S. Department of Labor (FY2021–FY2024).

The median sponsored salary is $103,031, with a typical P25–P75 band of $85,819–$167,089 across certified LCAs.

Transfers are 12% of its filings; most sponsorship is for new or continuing employment.

No — the employer attests it is not H-1B dependent on its LCA filings.

Stealth BioTherapeutics Inc. filed 2 certified LCAs in FY2024, the most recent fiscal year of U.S. DOL disclosure data.

Top worksites include Needham, MA, Norwich, NY.
Sponsorship data

Stealth BioTherapeutics Inc. H-1B data at a glance

Executive Summary

Stealth BioTherapeutics Inc. H-1B sponsorship at a glance, from public U.S. DOL LCA disclosure data (FY2021–FY2024).

  • Median certified salary is $103,031, typically $85,819–$167,089 (P25–P75).
  • 100% of certified filings are at or above the DOL prevailing wage.
  • Change-of-employer (transfer) share is 12% — most filings are for new or continuing employment.
  • Worksite footprint spans 2 states and 2 cities.
  • Most-sponsored roles: Senior Regulatory Operations Specialist, Associate Director, Quality Control, Senior Manager, Quality Control.
  • Filed 2 certified LCAs in FY2024, the most recent disclosure year.

Certified LCAs are a prerequisite to H-1B petitions, not visa approvals; one LCA can cover multiple workers. Descriptive only — not legal advice.

Salary Distribution

$80,465
$188,359
P25$85,819
Median$103,031
P75$167,089

The shaded band is the middle half of certified salaries (P25–P75); the bar spans the lowest to highest certified salary.

100% of certified filings at or above the DOL prevailing wage.

Wage Level Distribution

Level I
0%
Level II
100%
Level III
0%
Level IV
0%

Levels I–IV are DOL prevailing-wage experience tiers; 0% of filings are senior-level (III–IV).

Filing history

LCA filings by fiscal year

Certified LCAs per year

FY2021
3
FY2022
1
FY2023
1
FY2024
2
Fiscal yearCertifiedDeniedWithdrawnTotal
FY20213003
FY20221001
FY20231001
FY20242013

Case dispositions from the U.S. DOL OFLC disclosure files. Withdrawn are LCAs that were certified and later withdrawn by the employer; they still count toward Total.

See a single year in detail:
FY2021 ›FY2022 ›FY2023 ›FY2024 ›

All LCA filings

7 filings
Job titleSalaryLevelLocationFiledStatus
Associate Director, Quality Control
I-200-24171-129026
$188,359/yrIINeedham, MAJun 19, 2024Certified
Associate Director, Quality Control
I-200-24138-007260
$188,359/yrIINeedham, MAMay 17, 2024Certified, withdrawn
Senior Manager, Regulatory Affairs
I-200-24101-873004
$114,070/yrIINeedham, MAApr 10, 2024Certified
Senior Regulatory Operations Specialist
I-200-23067-833037
$91,992/yrIINeedham, MAMar 08, 2023Certified
Senior Regulatory Operations Specialist
I-200-22053-919907
$87,604/yrIINeedham, MAFeb 22, 2022Certified
Senior Manager, Quality Control
I-200-21201-471836
$160,000/yrIINorwich, NYJul 20, 2021Certified
Senior Regulatory Operations Specialist
I-200-21062-115981
$80,465/yrIINeedham, MAMar 03, 2021Certified

One row per LCA case (its latest version), from U.S. DOL OFLC disclosure data. Salaries are the offered wage, converted to a yearly figure. Certified LCAs are not visa approvals.

Every certified LCA needs its own Public Access File. Get the private gap check →
Sponsorship insights

How Stealth BioTherapeutics Inc. sponsors H-1B talent

Petition Mix

New employment  62%Transfer (change of employer)  12%Amendments & other  25%
Majority new-employment filings — Stealth BioTherapeutics Inc. primarily sponsors fresh H-1B cases.

Worker positions by LCA filing purpose, summed across FY2021–FY2024 disclosure records.

Filing Activity by Month

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec

Most active filing months: Mar and Feb — useful for timing transfer conversations.

Compliance Posture

H-1B Dependent
No
Willful Violator
No
Full-Time Positions
100%
At/Above Prevailing Wage
100%

Attestations from the employer's own LCA filings (Form ETA-9035), as disclosed by the U.S. DOL.

Roles & geography

Top sponsored roles & worksites

Top job titles

Senior Regulatory Operations Speci
4 · $85,132
Associate Director, Quality Contro
2 · $188,359
Senior Manager, Quality Control
1 · $160,000
Senior Manager, Regulatory Affairs
1 · $114,070

Top worksite locations

2 states · 2 cities

Needham, MA
7
Norwich, NY
1
ElevateStaffing.ai Platform

Built for H-1B compliance teams

The same DOL data on this page is what every H-1B sponsor must track for each worker. ElevateStaffing.ai automates it end-to-end:

LCA & Public Access Files
Track every Labor Condition Application and auto-assemble the Public Access File within the DOL's 1-business-day window.
I-9 & E-Verify
Centralize I-9s and E-Verify status with automatic alerts before any work authorization lapses.
Visa & I-983 deadlines
Never miss an H-1B extension, EAD renewal, or STEM OPT I-983 evaluation — every deadline is tracked and alerted.
Audit & site-visit ready
FDNS site-visit and USCIS audit ready: every LCA posting, wage memo and document in one timestamped vault.
Explore more

Similar H-1B sponsors by filing volume

Sponsor H-1B talent? Know your gaps before an auditor does.

Get the private PAF / LCA gap check for your own filings — free, one business day — then let ElevateStaffing.ai keep every LCA, PAF, I-9 and I-983 deadline audit-ready.

Get my private gap check →
Stealth BioTherapeutics Inc. · audit readiness
0 need attention2 to watch4 clear
Get my private gap check →